Jaden Schaefer

But

With that, like with the same amount of doctors on their app versus an actual office, they can 10x that.

So they could hire a lot of doctors and basically get 10 times the output for people.

So Lotus definitely isn't alone in kind of going after this idea of an AI doctor.

There's a bunch of different competitors.

Lightspeed recently backed Lightspeed.

doctrine.

There's a bunch of others.

For now, I think Lotus is kind of main competitor, like differentiator is price.

Their entire thing is free.

And of course, you know, some people are like, well, how long can you sustain free?

I mean, they have licensed doctors reviewing these files.

So I'm not sure if they're volunteering their time or Lotus is just kind of taking a hit at the beginning to try to, you know, onboard more people.

Their CEO said that the future monetization options might include something like a subscription or sponsored programs, but right now they're intentionally postponing making money, just trying to get users, I think, and their immediate goal is to basically refine the product, build trust, and just get as many patients using it as possible.

In a, you know, this is a healthcare system that is very used to long waits and kind of rushed visits.

And we hear a lot on the news about like doctors getting burnout and stuff.

And so I think because of this, Lotus is basically betting that AI is kind of, you know, if you mix it with a human and you have a human kind of overseeing everything, you can turn what people are already doing informally into something that looks and feels like real care.

Like I already go to chat GPT and ask all of these questions and put symptoms in.

And I mean, OpenAI knows that, that's why they launched OpenAI Health.

And so making this more formal and saying, look, you had the whole conversation, now just like get it reviewed by a doctor and you can go get your prescription, I think is a very, very smart direction.